
Artillegence Bio-Innovations Limited
Provides consultancy, investment, financing, and advisory services, as well as money transfer and financial services.
Provides consultancy, investment, financing, and advisory services, as well as money transfer and financial services.
Artillegence Bio-Innovations Limited (ABL) is a Public Limited Indian Non-Government Company incorporated in India on 16 April 1983 and has a history of 41 years and 11 months. Its registered office is in Howrah, West Bengal, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.40 Cr and a paid-up capital of Rs 7.32 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Artillegence Bio-Innovations Limited India are Vivek Dadriwal as Company Secretary, Pragati Bajaj as Company Secretary, and Sony Singh as Cfo. Sony Singh, Jay Singh, and Anil Das serve as directors at the Company.
Howrah, West Bengal, India
+91-XXXXXXXXXX
L51219WB1983PLC036190
036190
Public Limited Indian Non-Government Company
16 Apr 1983
30 Sep 2024
31 Mar 2024
Listed
Roc Kolkata
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jay Singh ![]() | Managing Director | 01-Apr-2023 | Current |
Vivek Dadriwal ![]() | Company Secretary | 04-Apr-2023 | Current |
Pragati Bajaj ![]() | Company Secretary | 04-Apr-2023 | Current |
Sony Singh | CFO | 17-Apr-2023 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sony Singh ![]() | Director | 01-Apr-2023 | Current |
Anil Das ![]() | Director | 01-Feb-2024 | Current |
Artillegence Bio-Innovations Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.34% increase. The company also saw a substantial fall in profitability, with a 61.68% decrease in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets | |||||||
Profit or Loss |
| ||||||
Net Worth | |||||||
EBITDA |
|
In 2022, Artillegence Bio-Innovations had a promoter holding of 0.03% and a public holding of 99.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Artillegence Bio-Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Artillegence Bio-Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artillegence Bio-Innovations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Artillegence Bio-Innovations Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Artillegence Bio-Innovations Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata.
Anil Kumar Das was appointed as a Director was appointed as a Director on 01 Feb 2024 & has been associated with this company since 1 year 1 month .
Sony Singh was appointed as a Cfo was appointed as a Cfo on 17 Apr 2023 & has been associated with this company since 1 year 11 months .
Vivek Dadriwal was appointed as a Company Secretary was appointed as a Company Secretary on 04 Apr 2023 & has been associated with this company since 1 year 11 months .
Pragati Bajaj was appointed as a Company Secretary was appointed as a Company Secretary on 04 Apr 2023 & has been associated with this company since 1 year 11 months .
Artillegence Bio-Innovations Limited was incorporated on 16 Apr 1983.
The authorized share capital of Artillegence Bio-Innovations Limited is ₹ 7.40 Cr and paid-up capital is ₹ 7.32 Cr.
Currently 6 directors are associated with Artillegence Bio-Innovations Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Artillegence Bio-Innovations Limited is 242/1 Netaji Subhash Road 1St Floor, Flat No. 102 India, Howrah, West Bengal, 711101.
The corporate identification number (CIN) of Artillegence Bio-Innovations Limited is L51219WB1983PLC036190 and the company number is 036190 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Artillegence Bio-Innovations Limited has risen by 23.34%.
The most recent Balance Sheet for Artillegence Bio-Innovations Limited was filed with the ROC on 31 Mar 2024.
DC
RS
HJ
NP
OJ
SP
AD
DS